Intriguingly, CDNs function as STING agonists and activate by traversing cell membranes through a recently discovered major transporter‐SLC19A1.132 Prospectively, understanding intracellular CDN trafficking for STING activation is significant for improved immunotherapeutic treatment of cancer and inflammatory diseases. Here, NT5C is linked to cancer.